Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HCV Genotype 1b”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00372983
What this trial is testing

Safety and PK Study of NOV-205 to Treat Chronic HCV Who Fail Standard Therapy

Who this might be right for
Hepatitis C
Cellectar Biosciences, Inc. 30
Not applicableUnknownNCT02865369
What this trial is testing

Regression of Liver Fibrosis After Daclatasvir and Asunaprevir Treatment

Who this might be right for
Chronic Hepatitis C
Sang Gyune Kim 103
Post-approval studies (Phase 4)Study completedNCT02580474
What this trial is testing

The Safety and Efficacy of Daclatasvir and Asunaprevir With Chronic HCV Genotype 1b Infection and Chronic Renal Failure

Who this might be right for
Hepatitis C
Myeong Jun Song 21
Testing effectiveness (Phase 2)Study completedNCT01435226
What this trial is testing

GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 170
Large-scale testing (Phase 3)Study completedNCT02973503
What this trial is testing

Study to Investigate the Efficacy of Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in Treatment-Naïve, HCV GT1b-Infected Patients, With Non-severe Fibrosis

Who this might be right for
Chronic HCV Infection
University Hospital, Clermont-Ferrand 117
Large-scale testing (Phase 3)WithdrawnNCT01858961
What this trial is testing

Open Label Trial to Compare BI 207127 to Telaprevir in HCV Patients

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim
Early research (Phase 1)Study completedNCT01740791
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Velpatasvir in Participants With Chronic HCV Infection

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 103
Large-scale testing (Phase 3)Study completedNCT01718158
What this trial is testing

Efficacy and Safety Evaluation of a Regimen Consisting of Peginterferon Lambda-1a + Ribavirin + Daclatasvir (Lambda + RBV + DCV) in HCV Genotype 1b Treatment naïve Patients or Prior Relapsers to Peginterferon Alfa + Ribavirin (Alfa + RBV) Therapy

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 444
Testing effectiveness (Phase 2)Study completedNCT01194037
What this trial is testing

A Phase 1b/2a Study of SC Hanferon™ in Combination With Ribavirin in Treatment-naïve Subjects With Genotype 1 Hepatitis C

Who this might be right for
Chronic Hepatitis C InfectionGenotype 1
HanAll BioPharma Co., Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT03485846
What this trial is testing

Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Daclatasvir in Treatment-Naїve Patients With Chronic Hepatitis C Genotype 1b

Who this might be right for
Chronic Hepatitis C Genotype 1b
R-Pharm 105
Post-approval studies (Phase 4)Ended earlyNCT03797066
What this trial is testing

ATTIC - Access To Treat in the Community

Who this might be right for
Hepatitis C, Chronic
King's College Hospital NHS Trust 13
Large-scale testing (Phase 3)Study completedNCT02517515
What this trial is testing

ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Treatment-Naïve and Treatment-Experienced, Non-Cirrhotic Asian Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 650
Early research (Phase 1)Study completedNCT01700179
What this trial is testing

Evaluation of Safety, Tolerability, and Antiviral Activity of ACH-0143102 Plus Ribavirin In Treatment-naive Hepatitis C Virus Infection Genotype 1b Participants

Who this might be right for
Chronic Hepatitis C Infection
Alexion Pharmaceuticals, Inc. 8
Large-scale testing (Phase 3)Study completedNCT02496078
What this trial is testing

Evaluation of Daclatasvir and Asunaprevir in Treatment-naive Subjects With Chronic Hepatitis C Genotype 1b Infection

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 207
Large-scale testing (Phase 3)Study completedNCT01767116
What this trial is testing

Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1b Infection

Who this might be right for
Chronic Hepatitis C Infection
AbbVie (prior sponsor, Abbott) 419
Large-scale testing (Phase 3)Study completedNCT01497834
What this trial is testing

Study in Combination With BMS-790052 and BMS-650032 in Japanese Hepatitis C Virus (HCV) Patients

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 224
Not applicableWithdrawnNCT02762448
What this trial is testing

Interferon-free Antiviral Treatment of HCV-Positive Genotype 1b Related Indolent Non-Hodgkin Lymphomas

Who this might be right for
Hepatitis c
Tainan Municipal Hospital
Early research (Phase 1)Study completedNCT01928147
What this trial is testing

A Phase 1a/1b Study of PPI-383 in Healthy Adults and Hepatitis C Patients

Who this might be right for
Hepatitis C, Chronic
Presidio Pharmaceuticals, Inc. 114
Testing effectiveness (Phase 2)Study completedNCT01434498
What this trial is testing

GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) in Interferon Ineligible or Intolerant Subjects With Chronic Genotype 1a or 1b Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Genotype 1a or 1b HCV Infection
Gilead Sciences 163
Early research (Phase 1)Study completedNCT01144936
What this trial is testing

Study of VX-985 in Subjects With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Vertex Pharmaceuticals Incorporated 21
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation